(Q48869950)

16 February 2018

title

Memantine effects on behaviour in moderately severe to severe Alzheimer's disease: a post-marketing surveillance study. (English)

1 reference

16 February 2018

0 references

2

Nicola Vanacore

1 reference

16 February 2018

Francesca Clerici

1

1 reference

16 February 2018

Antonietta Elia

3

1 reference

16 February 2018

Stefania Spila-Alegiani

4

1 reference

16 February 2018

Simone Pomati

5

1 reference

16 February 2018

Roberto Da Cas

6

1 reference

16 February 2018

Roberto Raschetti

7

1 reference

16 February 2018

Claudio Mariani

8

1 reference

16 February 2018

Memantine Lombardy Study Group

9

1 reference

16 February 2018

publication date

17 May 2011

1 reference

16 February 2018

published in

Neurological Sciences

1 reference

16 February 2018

volume

33

1 reference

16 February 2018

issue

1

1 reference

16 February 2018

page(s)

23-31

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/s10072-011-0618-0

exact match

0 references

cites work

The spectrum of behavioral changes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Predictors of disease course in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Patient and caregiver characteristics and nursing home placement in patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Cholinesterase Inhibitor Therapies and Neuropsychiatric Manifestations of Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Memantine in moderately-severe-to-severe Alzheimer's disease: a postmarketing surveillance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Behavioral disorders in Alzheimer disease: a transcultural perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Validation of the Cumulative Illness Rating Scale in a geriatric residential population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Behavioural and psychological syndromes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

FDA standards--good enough for government work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Memantine in moderate-to-severe Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Eligibility of Alzheimer's disease clinic patients for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Developing improved observational methods for evaluating therapeutic effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0618-0

Mini-Mental State Examination: a normative study in Italian elderly population

21 January 2018

1 reference

12 December 2020

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

12 December 2020

Atypical antipsychotics for aggression and psychosis in Alzheimer's disease

1 reference

12 December 2020

Haloperidol for agitation in dementia.

1 reference

12 December 2020

Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies

1 reference

12 December 2020

Memantine for dementia

1 reference

12 December 2020

10.1007/S10072-011-0618-0

Identifiers

DOI

1 reference

16 February 2018

PubMed ID

21584738

1 reference

16 February 2018